Zegeng M. Li

Key Laboratory Of Xin'an Medicine
Hefei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

TikTok, RedNote, and Bilibili as sources of medical information on chronic obstructive pulmonary disease: a cross-platform content analysis.

TikTok, RedNote, and Bilibili as sources of medical information on chronic obstructive pulmonary disease: a cross-platform content analysis.

Journal: Journal of thoracic disease

Published: April 03, 2026

TikTok, Xiaohongshu, and Bilibili as sources of medical information on lung cancer: a multi-platform content evaluation.

TikTok, Xiaohongshu, and Bilibili as sources of medical information on lung cancer: a multi-platform content evaluation.

Journal: Journal of thoracic disease

Published: March 25, 2026

From immunological mechanisms to targeted therapies: a bibliometric analysis in the domain of research concerning neutrophil extracellular traps and pulmonary diseases (2006-2025).

From immunological mechanisms to targeted therapies: a bibliometric analysis in the domain of research concerning neutrophil extracellular traps and pulmonary diseases (2006-2025).

Journal: Frontiers in immunology

Published: March 24, 2026

SCFAs inhibited NETosis to alleviate lung inflammation in COPD: a potential role for GPR43.

SCFAs inhibited NETosis to alleviate lung inflammation in COPD: a potential role for GPR43.

Journal: Respiratory research

Published: January 24, 2026

Global trends and projections of tracheal, bronchial, and lung cancer (TBL) associated with secondhand smoke (SHS) exposure in women: insights of the Global Burden of Disease (GBD) study 2021 from 1990 to 2021 and prediction to 2035.

Global trends and projections of tracheal, bronchial, and lung cancer (TBL) associated with secondhand smoke (SHS) exposure in women: insights of the Global Burden of Disease (GBD) study 2021 from 1990 to 2021 and prediction to 2035.

Journal: Journal of thoracic disease

Published: December 18, 2025

Mechanism of Qibai Pingfei Capsule in ameliorating COPD-associated inflammation via the ABCA3/PPARγ/NF-κB pathway: A serum-targeted metabolomics and lipidomics study.

Mechanism of Qibai Pingfei Capsule in ameliorating COPD-associated inflammation via the ABCA3/PPARγ/NF-κB pathway: A serum-targeted metabolomics and lipidomics study.

Journal: Journal of pharmaceutical and biomedical analysis

Published: November 28, 2025

Targeting neutrophil extracellular traps (NETs): a promising immunotherapeutic approach for pulmonary diseases.

Targeting neutrophil extracellular traps (NETs): a promising immunotherapeutic approach for pulmonary diseases.

Journal: Molecular biology reports

Published: November 02, 2025

Sangma Zhike Formula alleviates airway inflammation and hyperresponsiveness in rats with postinfectious cough by inhibiting the TRPV1-SP/CGRP and pyroptosis pathways

Sangma Zhike Formula alleviates airway inflammation and hyperresponsiveness in rats with postinfectious cough by inhibiting the TRPV1-SP/CGRP and pyroptosis pathways

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: September 29, 2025

Research frontiers and emerging trends in sex and gender differences in chronic obstructive pulmonary disease: a bibliometric analysis.

Research frontiers and emerging trends in sex and gender differences in chronic obstructive pulmonary disease: a bibliometric analysis.

Journal: Journal of thoracic disease

Published: September 25, 2025

Shenqi Tiaoshen formula attenuates COPD through METTL16-dependent m6A regulation of MALT1-NF-κB.

Shenqi Tiaoshen formula attenuates COPD through METTL16-dependent m6A regulation of MALT1-NF-κB.

Journal: Journal of ethnopharmacology

Published: September 09, 2025

Mitochondrial DNA methylation predicts immunotherapy response and prognosis in lung adenocarcinoma: evidence from scRNA-Seq and machine learning.

Mitochondrial DNA methylation predicts immunotherapy response and prognosis in lung adenocarcinoma: evidence from scRNA-Seq and machine learning.

Journal: BMC cancer

Published: August 05, 2025

Efficacy and health economics of Bufei Yishen granules in patients with frequent exacerbator phenotype in the stable phase of chronic obstructive pulmonary disease: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.

Efficacy and health economics of Bufei Yishen granules in patients with frequent exacerbator phenotype in the stable phase of chronic obstructive pulmonary disease: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.

Journal: Frontiers in medicine

Published: July 09, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026